Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvage allogeneic hematopoietic stem cell transplantation for severe aplastic anemia with refractory active infection
ChiCTR-OCH-14005190Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Oct 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of allogeneic hematopoietic stem cell transplantation in aplastic anemia, sponsored by Shanghai Children's Medical Center. Primary endpoints: Overall survival and Disease-free survival. Started Oct 2014; status: recruiting.
02
Drugs
allogeneic hematopoietic stem cell transplantation
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on ChiCTR-OCH-14005190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14005190.